Ocugen is trading at MXN 15.00, up +7.14%, amid a supportive biotech backdrop, though no direct cause is established. - No confirmed company-specific announcement on October 28 explains the move; a report about Ocugen’s European affiliate reflects its October 6 announcement, not fresh news. - Sector context shows XBI up 2.18% amid positive clinical and regulatory news across the industry; no trading-volume data was available.